Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors

Journal of Neurosurgery

Volumn 118, Issue 6, 2013, Pages 1183-1187

  Saria, Marlon G ^a   Corle, Courtney ^a   Hu, Jethro ^b   Rudnick, Jeremy D ^b   Phuphanich, Surasak ^b   Mrugala, Maciej M ^c,d   Crew, Laura K ^a,d   Bota, Daniela A ^a,c,e   Fu, Beverly Dan ^c   Kim, Ryan Y ^a   Brown, Tiffany ^a   Feely, Homira ^a,f   Brechlin, Joanne ^a   Brown, Bradley D ^a   Drappatz, Jan ^c,g   Wen, Patrick Y ^c,g   Chen, Clark C ^f   Carter, Bob ^f   Lee, Jong Woo ^c   Kesari, Santosh ^a,h  

^a Department of Neurosciences ^*  (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antiepileptic drug; Oncology; Primary brain tumor; Seizure

Indexed keywords

HARKOSERIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN TUMOR; DRUG ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GLIOBLASTOMA; GLIOMA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEIZURE; TONIC CLONIC SEIZURE; UNIVERSITY HOSPITAL;

ACETAMIDES; ADULT; ANTICONVULSANTS; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 84878716060     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.1.JNS12397     Document Type: Article

References (14)

1. Beydoun A, D'Souza J, Hebert D, Doty P: Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother 9:33-42, 2009
2. Chung SS: Lacosamide: new adjunctive treatment option for partial-onset seizures. Expert Opin Pharmacother 11:1595-1602, 2010
3. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886-1893, 2000
4. Halford JJ, Lapointe M: Clinical perspectives on lacosamide. Epilepsy Curr 9:1-9, 2009
5. Johannessen Landmark C, Patsalos PN: Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10:119-140, 2010
6. Maschio M, Dinapoli L, Mingoia M, Sperati F, Pace A, Pompili A, et al: Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol 258:2100-2104, 2011
7. Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A: Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol 67:343-346, 2010
8. Rossetti AO, Stupp R: Epilepsy in brain tumor patients. Curr Opin Neurol 23:603-609, 2010
9. Rudà R, Trevisan E, Soffietti R: Epilepsy and brain tumors. Curr Opin Oncol 22:611-620, 2010
10. Smith KC: The management of seizures in brain tumor patients. J Neurosci Nurs 42:28-37, 2010
11. van Breemen MS, Wilms EB, Vecht CJ: Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421-430, 2007 (Pubitemid 46551867)
12. Vecht CJ, van Breemen M: Optimizing therapy of seizures in patients with brain tumors. Neurology 67 (12 Suppl 4):S10-S13, 2006 (Pubitemid 44967990)
13. Villanueva V, Codina M, Elices E: Management of epilepsy in oncological patients. Neurologist 14 (6 Suppl 1):S44-S54, 2008
14. Yap KY, Chui WK, Chan A: Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther 30: 1385-1407, 2008